Cigna Group (CI) EBITDA Margin (2017 - 2026)

Cigna (CI) posted EBITDA Margin of 3.73% for Q2 2026, up 8.46% sequentially from 3.44% in Q1 2026, and up 30.0% YoY from 2.87% in Q2 2025.

Cigna Group (CI) EBITDA Margin (2017 - 2026) Analysis & Trends

Cigna has reported EBITDA Margin for 10 years, with the latest figure at 3.73% in Q2 2026.

Quarterly EBITDA Margin rose 30.0% year-over-year to 3.73% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 3.53% (up 8.0% YoY) and the FY2025 annual result came in at 3.35%, down 46.0% from the prior year.
EBITDA Margin advanced to 3.73% in Q2 2026 per CI's latest filing, from 3.44% in the prior quarter.
Over five years, EBITDA Margin peaked at 5.21% in Q2 2022 and troughed at 3.01% in Q1 2025.
A 5-year average of 4.0% and a median of 3.96% in 2024 frame the typical range for EBITDA Margin.
The sharpest annual moves came in 2022 and 2025: EBITDA Margin soared 44 bps in 2022, then slumped 93 bps in 2025.
Over 5 years, EBITDA Margin stood at 3.82% in 2022, then gained by 5 bps to 4.03% in 2023, then fell by 18 bps to 3.31% in 2024, then declined by 2 bps to 3.24% in 2025, then climbed by 15 bps to 3.73% in 2026.
According to Business Quant data, EBITDA Margin over the past three periods registered 3.73%, 3.44%, and 3.24% for Q2 2026, Q1 2026, and Q4 2025 respectively.

Download Data